knowledge -WSS

knowledge

author：fashion 2025-09-27 15:49:30 - browse：7

Robert F. Kennedy Jr. arrives in the lobby of Trump Tower in New York for a meeting with President-elect Donald Trump. Evan Vucci/AP

WASHINGTON — Outspoken vaccine critic Robert Kennedy Jr. said Tuesday that he had accepted a position in Donald Trump’s administration as chair of a panel on vaccine safety and scientific integrity, in what would be the clearest sign yet of the president-elect’s suspicions about vaccines.

Kennedy’s remarks followed his meeting with the president-elect at Trump Tower and immediately sparked outrage from scientists, pediatricians, and public health experts, who fear the incoming administration could give legitimacy to skeptics of childhood immunizations despite a huge body of scientific research demonstrating that vaccines are safe. Many of those skeptics believe vaccines are a cause of autism.

Hours later, Trump spokeswoman Hope Hicks said in a statement that the president-elect was “exploring the possibility of forming a commission on Autism,” but said “no decisions have been made at this time.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Printout prescription drug information shouldn’t go digital

WSS

Printout prescription drug information shouldn’t go digital

To avoid data mishandling cases, universities eye AI and other tools

To bolster infectious disease surveillance, genomics powerhouses team up

Medicare Advantage proposed rates disappoint insurers

What we’ve learned from the Aduhelm mess

Readout LOUD podcast: How biotech is using artificial intelligence

knowledge

knowledge

entertainment

Virginia high school admissions case could be legal follow

Medicare drug price lawsuits could be good politics for Biden

Wildfire smoke exposes gaps in outdoor worker protections

KalVista pill reduced swelling 'attacks' caused by genetic disease

Medical records are filled with copy

Inaction leaves children at risk from dangerous chemotherapy drug

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

FDA sets aggressive timeline for overhauling inspection procedures

23andMe had bad news about my health. I wish a person had delivered it

PhRMA lawsuit over Medicare drug price negotiation tossed

focus

Key House Republican on health care plans exit from Congress

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Private equity deals in Medicare Advantage declines

Robert F. Kennedy is pitching centrism on health, even on abortion

There's an unseen cost to disruptive road

entertainment

hotspot

entertainment

hotspot